Ekso Bionics Holdings Inc (EKSO)

[Money maker 110]

I believe at this point the 25% reduction is necessary to help meet Q2 expectations which in my view maybe their only saving grace. Get rid of all non essential persons and payroll expenses until sales numbers justify reinstating the positions. I also think management should all take a cut in pay to let investors know they are serious about turning this around. The cash burn wasn't and isn't sustainable with those sales numbers without repeated dilution. I for one feel this was a smart move and I'm pretty sure Ekso is doing everything possible to meet or beat expectations. Until investors realize this is a viable company that is growing revenue quarter after quarter I think they will struggle. I think everything is riding on Q2 numbers.